Erratum: Pediatric headache: A clinical review (Headache (2012) 52 (333-339) DOI:10.1111/j.1526-4610.2011.02086.x);Pediatric headache: A clinical review

Headache

Volumn 52, Issue 2, 2012, Pages 333-339

  Jacobs, Howard ^a   Gladstein, Jack ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

headache; migraine; pediatrics

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; BOTULINUM TOXIN A; CHLORPROMAZINE; CYPROHEPTADINE; DIHYDROERGOTAMINE; ERGOTAMINE; GABAPENTIN; GINKGO BILOBA EXTRACT; IBUPROFEN; KETOROLAC; MAGNESIUM; MAGNESIUM SULFATE; METHYLPREDNISOLONE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PETASITES HYBRIDUS EXTRACT; PREGABALIN; PROCHLORPERAZINE; PROMETHAZINE; PROPRANOLOL; RIBOFLAVIN; TANACETUM PARTHENIUM EXTRACT; TIZANIDINE; TOPIRAMATE; TRIPTAN DERIVATIVE; UBIDECARENONE; UNINDEXED DRUG; VALPROIC ACID; ZONISAMIDE;

ANXIETY; BEHAVIOR THERAPY; CLUSTER HEADACHE; DISEASE CLASSIFICATION; DRUG SAFETY; EMERGENCY CARE; EPISODIC MIGRAINE; EPISODIC TENSION HEADACHE; HEADACHE; HUMAN; HYPNOSIS; INTERNATIONAL CLASSIFICATION OF DISEASES; LIFESTYLE; MIGRAINE; NAUSEA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE; PEDIATRIC HEADACHE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE; TRANSFORMED MIGRAINE; WEIGHT GAIN;

EID: 84857052319     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02126_2.x     Document Type: Erratum

References (85)

1. Bille B,. Migraine in school children. Acta Paediatric Supplement. 1962; 136: 1-151.
2. Abu-Arafeh I, Razak S, Sivaraman B, Graham C,. Prevalence of headache and migraine in children and adolescents: A systematic review of population-based studies. Dev Med Child Neurol. 2010; 52: 1088-1097.
3. Headache Classification Subcommittee of the International Headache Society. International Classification of Headache Disorders, 2nd edn. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
4. Rothner AD,. Headaches in children and adolescents: Update 2001. Semin Pediatr Neurol. 2001; 8: 2-6. (Pubitemid 32275244)
5. Vahlquist B,. Migraine in children. Int Arch Allergy. 1955; 7: 348-355.
6. Prensky A,. Migraine and migraine variants in pediatric patients. Pediatr Clin North Am. 1976; 23: 461-471.
7. Hershey AD, Winner P, Kabbouche MA, et al,. Use of the ICHD II criteria in the diagnosis of pediatric migraine. Headache. 2005; 45: 1288-1297. (Pubitemid 350004941)
8. Swadron SP,. Pitfalls in the management of headache in the emergency department. Emerg Med Clin North Am. 2010; 28: 127-147. viii-ix.
9. Cady RK, Dodick DW, Levine HL, et al,. Sinus headache: A neurology, otolanyngology, allergy and primary care consensus on diagnosis and treatment. Mayo Clin Proc. 2005; 80: 908-916. (Pubitemid 40911465)
10. Cuvellier JC, Lepine A,. Childhood periodic syndromes. Pediatr Neurol. 2010; 42: 1-11.
11. Virtanen R, Aromaa M, Rautava P, et al,. Changing headache from preschool age to puberty: A controlled study. Cephalalgia. 2007; 27: 294-303. (Pubitemid 46434954)
12. Wang SJ, Fuh JL, Juang KD, Lu SR,. Migraine and suicidal ideation in adolescents aged 13 to 15 years. Neurology. 2009; 72: 1146-1152.
13. Miller VA, Palermo TM, Powers SW, Scher MS, Hershey AD,. Migraine headaches and sleep disturbances in children. Headache. 2003; 43: 362-368. (Pubitemid 36417766)
14. Gilman DK, Palermo TM, Kabbouche MA, Hershey AD, Powers SW,. Primary headache and sleep disturbances in adolescents. Headache. 2007; 47: 1189-1194. (Pubitemid 47457772)
15. Mack KJ, Johnson JN, Rowe PC,. Orthostatic intolerance and the headache patient. Semin Pediatr Neurol. 2010; 17: 109-116.
16. Seidel S, Karwautz A, Wagner G, et al,. Migraine in patients with eating disorders: A study using a sister-pair comparison design. Headache. 2011; 51: 220-225.
17. Yamane LE, Montenegro MA, Guerreiro MM,. Comorbidity headache and epilepsy in childhood. Neuropediatrics. 2004; 35: 99-102. (Pubitemid 38639316)
18. Hershey AD, Powers SW, Nelson TD, et al,. Obesity in the pediatric headache population: A multicenter study. Headache. 2009; 49: 170-177.
19. Pakalnis A, Gladstein J,. Headaches and hormones. Semin Pediatr Neurol. 2010; 17: 100-104.
20. Fekkes M, Pijpers FI, Verloove-Vanhorick SP,. Bullying behavior and associations with psychosomatic complaints and depression in victims. J Pediatr. 2004; 144: 17-22. (Pubitemid 38091416)
21. Gladstein J, Mack KJ,. Chronic daily headache in adolescents. Pediatr Ann. 2005; 34: 472-479. (Pubitemid 40904411)
22. Lewis DW, Ashwal S, Dahl G, et al,. Practice parameter: Evaluation of children and adolescents with recurrent headaches: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002; 59: 490-498. (Pubitemid 34919980)
23. Lewis DW, Dorbad D,. The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations. Headache. 2000; 40: 629-632.
24. Lipton RB, Stewart WF, Celentano DD, Reed ML,. Undiagnosed migraine headache. A comparison of symptom base and reported physician diagnosis. Arch Intern Med. 1992; 152: 1273-1278.
25. Stewart WF, Staffa J, Lipton RB, Ottman R,. Familial risk of migraine: A population based study. Ann Neurol. 1997; 41: 166-172. (Pubitemid 27082097)
26. Kernick D, Reinhold D, Campbell JL,. Impact of headache on young people in a school population. Br J Gen Pract. 2009; 59: 678-681.
27. Fujita M, Fujiwara J, Maki T, Shibasaki K, Shigeta M, Nii J,. Pediatric chronic daily headache associated with school phobia. Pediatr Int. 2009; 51: 621-625.
28. Zeltzer L,. Conquering Your Child's Pain: A Pediatrician's Guide for Reclaiming a Normal Childhood. New York: Harper Collins; 2005.
29. Neinstein LS,. The office visit, interview techniques, and recommendations to parents. In:, Neinstein LS, ed. Adolescent Health Care: A Practical Guide. Williams and Wilkins; 1996: 46-60.
30. Lewis DW, Kellstein D, Dahl G, et al,. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002; 42: 780-786. (Pubitemid 35291512)
31. Hamalainen ML, Hoppu K, Valkeila E, Santavouri P,. Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997; 48: 102-107.
32. Ueberall MA, Wenzel D,. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999; 52: 1507-1510. (Pubitemid 29190554)
33. Winner P, Rothner AD, Saper J, et al,. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000; 106: 989-997.
34. Ahonen K, Hamalainen ML, Rantala H, Hoppu K,. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial. Neurology. 2004; 62: 883-887. (Pubitemid 38435772)
35. Hamalainen ML, Hoppu K, Santavuori P,. Sumatriptan for migraine attacks in children: A randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology. 1997; 48: 1100-1103.
36. Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J,. Zolmitriptan oral tablet in migraine treatment: High placebo responses in adolescents. Headache. 2006; 46: 101-109.
37. Linder S, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW,. Efficacy and tolerability of almotriptan in adolescents: A randomized double blinded, placebo-controlled trial. Headache. 2008; 48: 1326-1336.
38. Lewis DW, Winner P, Wasiewski W,. The placebo responder rate in children and adolescents. Headache. 2005; 45: 232-239. (Pubitemid 40393213)
39. Jones J, Sklar D, Dougherty J, White W,. Randomized double-blind trial of intravenous prochloperazine for the treatment of acute headache. JAMA. 1989; 261: 1174-1176. (Pubitemid 19062453)
40. Bigal ME, Bordini CA, Speciali JG,. Intravenous chlorpromazine in the emergency department treatment of migraines: A randomized control trial. J Emerg Med. 2002; 23: 141-148.
41. Schulman E, Dermott K,. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache. 2003; 43: 729-733. (Pubitemid 36993010)
42. Kopjas TL,. Migraine treatment with dexamethasone. Headache. 1967; 7: 77-78.
43. Gallagher RM,. Emergency treatment of intractable migraine. Headache. 1986; 26: 77-78.
44. Raskin N,. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986; 36: 995-997. (Pubitemid 16098249)
45. Mauskop A,. Intravenous magnesium sulfate rapidly alleviates headache of various types. Headache. 1996; 36: 154-160. (Pubitemid 26116923)
46. Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P,. Intravenous valproate sodium (depacon) aborts migraine rapidly: A preliminary report. Headache. 2000; 40: 720-723.
47. Kabbouche MA, LeCates SL, Vaughan P, Cherney S, Powers SW, Hershey AD,. Intractable headache response in a pediatric acute care unit (abstract). Cephalalgia. 2009; 29 (Suppl. 1): 16.
48. Lewis D, Ashwal S, Hershey A, et al,. Practice parameter: Pharmacological treatment of migraine headache in children and adolescents: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004; 63: 2215-2224. (Pubitemid 40024327)
49. Lewis D, Winner P, Saper J, et al,. Randomized double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics. 2009; 123: 924-934.
50. Hershey AD, Powers SW, Bentti AL, deGrauw TJ,. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000; 40: 539-549. (Pubitemid 30497412)
51. Ludvigsson J,. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974; 50: 109-115.
52. Forsythe WI, Gillies D, Sills MA,. Propranolol (Inderal) in the treatment of childhood migraine. Dev Med Child Neurol. 1984; 26: 737-741. (Pubitemid 15175452)
53. Olness K, MacDonald JT, Uden DL,. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987; 79: 593-597. (Pubitemid 17051427)
54. Lewis D, Diamond S, Scott D, Jones V,. Prophylactic treatment of pediatric migraine. Headache. 2004; 44: 230-237. (Pubitemid 38436685)
55. Swanson JW,. Topiramate for migraine prevention. Curr Neurol Neurosci Rep. 2005; 5: 77-78.
56. Tzellos TG, Toulis KA, Goulis DG, et al,. Gabapentin and pregabalin in the treatment of fibromyalgia. A systematic review and meta-analysis. J Clin Pharm Ther. 2010; 35: 639-656.
57. Linde K, Rossnagel K,. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev. 2004;(2): CD003225.
58. Comer SD, Haney M, Fischman MW, Foltin RW,. Cyproheptadine produced modest increases in total caloric intake by humans. Physiol Behav. 1997; 62: 831-839. (Pubitemid 27412642)
59. Colombo B, Annovazzi PO, Comi G,. Therapy of primary headaches: The role of antidepressants. Neurol Sci. 2004; 25 (Suppl. 3): S171-S175. (Pubitemid 41461986)
60. Chronicle E, Mulleners W,. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev. 2004;(3): CD003226.
61. Fava M,. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am. 1997; 20: 427-451.
62. Kohen D, Zajac R,. Self-hypnosis training for headache in children and adolescents. J Pediatr. 2007; 150: 635-639. (Pubitemid 46755808)
63. Nestoriuc Y, Martin A,. Efficacy of biofeedback for migraine: A meta-analysis. Pain. 2007; 128: 111-127. (Pubitemid 46216605)
64. Kemper K, Sarah R, Silver-Highfield E, Xiarhos E, Barnes L, Berde C,. On pins and needles? Pediatric pain patients' experience with acupuncture. Pediatrics. 2000; 105: 941-947. (Pubitemid 30198732)
65. Backer M, Grossman P, Schneider J, et al,. Acupuncture in migraine, investigation of autonomic effects. Clin J Pain. 2008; 24: 106-115. (Pubitemid 351156510)
66. Taylor F,. Nutraceuticals and headache: The biological basis. Headache. 2011; 51: 484-501.
67. Bruijn J, Duivenvoorden H, Passchier J, Locher H, Dijkstra N, Arts WF,. Medium-dose riboflavin as a prophylactic agent in children with migraine: A preliminary placebo-controlled, randomized, double-blind, cross-over trial. Cephalalgia. 2010; 30: 1426-1434.
68. Sutherland A, Sweet B,. Butterbur: An alternative therapy for migraine prevention. Am J Health Syst Pharm. 2010; 67: 705-711.
69. Esposito M, Carotenuto M,. Gingkolide B complex efficacy for brief prophylaxis of migraine in school-aged children: And open-label study. Neurol Sci. 2011; 32: 79-81.
70. Pothman R, Danesch U,. Migraine prevention in children and adolescents: Results of an open study with special butterbur root extract. Headache. 2005; 45: 196-203. (Pubitemid 40393207)
71. Condo M, Posar A, Arbizzani A, Parmeggiani A,. Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain. 2009; 10: 361-365.
72. Tepper S,. Complementary and alternative treatments for childhood headaches. Curr Pain Headache Rep. 2008; 12: 379-383.
73. Usai S, Grazzi L, Bussone G,. Ginkolide B as migraine preventative treatment in young age; results at 1-year follow-up. Neurol Sci. 2011; 32 (Suppl. 1): S197-S199.
74. Sun-Edelstein C, Mauskop A,. Alternative headache treatments; nutraceuticals, behavioral and physical treatments. Headache. 2011; 51: 469-483.
75. Pittler MH, Ernst E,. Feverfew for preventing migraine. The Cochrane Library. 2009; 1: 1-13.
76. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J,. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999; 19: 107-114. (Pubitemid 29170106)
77. Hershey AD, Powers SW, Vockell LB, LeCates S, Kabbouche MA, Maynard MK,. PedMIDAS development of a questionnaire to assess disability of migraines in children. Neurology. 2001; 57: 2034-2039. (Pubitemid 33126871)
78. Chan V, McCabe EJ, MacGregor D,. Botox treatment for migraine and chronic daily headache in adolescents. J Neurosci Nurs. 2009; 41: 235-243.
79. Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR,. Chronic daily headache prophylaxis with tizanidine: A double-blind placebo-controlled multicenter outcome study. Headache. 2002; 42: 470-482. (Pubitemid 37011819)
80. Ashkenazi A, Benlifer A, Korenblit J, Silberstein SD,. Zonisamide for migraine prophylaxis in refractory patients. Cephalalgia. 2006; 26: 1199-1202. (Pubitemid 44359340)
81. Bigal M, Rapoport A, Sheftel F, Tepper D, Tepper S,. Memantine in the preventative treatment of refractory migraine. Headache. 2008; 48: 1337-1342.
82. Diener H-C, Montagna P, Gacs G, et al,. Efficacy and tolerability of diclofenac potassium sachets in migraine: A randomized double-blind cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia. 2006; 26: 537-547. (Pubitemid 43601218)
83. Lipton RB, Grosberg B, Singer RP, et al,. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT). Cephalalgia. 2010; 30: 1336-1345.
84. Brandes JL, Cady RK, Freitag FG, et al,. Needle-free subcutaneous sumatriptan (Sumavel DosePro): Bioequivalence and ease of use. Headache. 2009; 49: 1435-1444.
85. Pierce M, Marbury T, O'Neill T, Seigel S, Du W, Sebree T,. Zelrix: A novel transdermal formulation of sumatriptan. Headache. 2009; 49: 817-825.